ROCAMBOLI STEPHEN has filed 4 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 33000 shares of Esperion Therapeutics, Inc. ($ESPR) on May 29, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | Esperion Therapeutics, Inc. | $ESPR | ROCAMBOLI STEPHEN | Director | A | Common Stock | 33000 | $0.00 | 69,261.0000 | 197,848,886 | 91.01% | 0.02% |
| May 29, 2025 | Esperion Therapeutics, Inc. | $ESPR | ROCAMBOLI STEPHEN | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 197,848,886 | 9999.99% | 0.02% |
| May 23, 2024 | Esperion Therapeutics, Inc. | $ESPR | ROCAMBOLI STEPHEN | Director | A | Common Stock | 23000 | $0.00 | 36,261.0000 | 0 | 173.44% | 0.00% |
| May 23, 2024 | Esperion Therapeutics, Inc. | $ESPR | ROCAMBOLI STEPHEN | Director | A | Stock Option (right to buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |